CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
41.765
0.42%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.105
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.019343 %
Charges from full value of position ($-3.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.019343%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.002879 %
Charges from full value of position ($-0.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.002879%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 41.94
Open 41.91
1-Year Change 5.13%
Day's Range 41.72 - 41.91
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 4, 2025 41.940 -0.340 -0.80% 42.280 42.420 41.755
Feb 3, 2025 42.535 -0.250 -0.58% 42.785 42.965 42.505
Jan 31, 2025 42.890 0.045 0.11% 42.845 43.160 42.725
Jan 30, 2025 42.895 0.775 1.84% 42.120 43.050 41.770
Jan 29, 2025 42.405 -2.145 -4.81% 44.550 44.550 41.955
Jan 28, 2025 43.720 0.090 0.21% 43.630 44.480 43.200
Jan 27, 2025 43.570 -0.005 -0.01% 43.575 44.485 43.515
Jan 24, 2025 43.655 0.335 0.77% 43.320 44.170 43.265
Jan 23, 2025 44.635 -0.945 -2.07% 45.580 45.815 44.285
Jan 22, 2025 45.830 0.465 1.03% 45.365 45.995 45.365
Jan 21, 2025 45.505 0.495 1.10% 45.010 45.695 44.855
Jan 20, 2025 45.065 0.185 0.41% 44.880 45.090 44.665
Jan 17, 2025 44.760 0.115 0.26% 44.645 44.880 44.400
Jan 16, 2025 44.485 0.375 0.85% 44.110 44.680 43.660
Jan 15, 2025 44.195 0.035 0.08% 44.160 44.770 44.085
Jan 14, 2025 44.135 -0.565 -1.26% 44.700 44.830 43.980
Jan 13, 2025 44.760 0.980 2.24% 43.780 44.955 43.780
Jan 10, 2025 43.985 0.175 0.40% 43.810 44.220 43.610
Jan 9, 2025 44.100 0.285 0.65% 43.815 44.320 43.730
Jan 8, 2025 43.840 0.225 0.52% 43.615 44.060 43.310

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

People also watch

ETH/USD

2,774.96 Price
+4.920% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

2.52 Price
+2.760% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01258

US100

21,370.80 Price
-0.520% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,868.43 Price
+0.900% 1D Chg, %
Long position overnight fee -0.0002%
Short position overnight fee -0.0080%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading